Outcomes Following Acute Plasma Exchange for MOGAD
Neurology® Podcast
Dr. Justin Abbatemarco talks with Drs. John Chen and Smathorn Thakolwiboon about the outcomes following plasma exchange in MOGAD and explore how the findings from this study can inform patient care. Read the related article in . Disclosures can be found at .
info_outline
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 2
Neurology® Podcast
In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about overcoming funding challenges, the importance of rigor and reputation, unmet needs in neurology, and leveraging AI in neurology research. Disclosures can be found at .
info_outline
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 1
Neurology® Podcast
In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about recent advancements in neurology, emerging genomic therapies, the evolving understanding of long COVID, and current NINDS priorities. Disclosures can be found at .
info_outline
Updates on All Things Myositis – Part 2
Neurology® Podcast
In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about treatment options, real-world case studies, and future directions in myositis research. Disclosures can be found at .
info_outline
Updates on All Things Myositis – Part 1
Neurology® Podcast
In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about the different types of myositis, approaches to diagnosis, available diagnostic tools, and the evolving roles of MRI and biopsy in clinical practice. Disclosures can be found at .
info_outline
September 2025 Recall: Topics on Epilepsy
Neurology® Podcast
The September 2025 Recall replay highlights four previously released episodes focused on epilepsy. Dr. Halley Alexander begins the series with Dr. Juan Luis Alcala-Zermeno, discussing outcomes of epilepsy surgery in patients with tonic-clonic seizures. She then speaks with Dr. Samuel W. Terman about patients’ perceived seizure risk, seizure risk tolerance, and approaches to risk counseling. In the third episode, Dr. Alexander is joined by Dr. Vineet Punia to explore factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized...
info_outline
GLP-1RA–Associated Diabetic Lumbosacral Radiculoplexus and Common Fibular Neuropathies
Neurology® Podcast
Dr. Alex Menze talks with Dr. Christopher J. Klein about the clinical presentation, diagnosis, and management of diabetic lumbosacral radiculoplexus neuropathy and common fibular neuropathy in the context of GLP-1RA. Read the related article in . Disclosures can be found at .
info_outline
Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years
Neurology® Podcast
Dr. Jeff Ratliff talks with Dr. Valtteri Kaasinen about the clinical challenges of diagnosing Parkinson disease and how that diagnosis can evolve over time. Read the related article in . Disclosures can be found at .
info_outline
FDG-PET-Based Machine Learning Framework to Support Neurologic Decision-Making
Neurology® Podcast
Dr. Trey Bateman talks with Dr. David T. Jones about how the StateViewer system leverages FDG-PET imaging and machine learning to improve diagnostic accuracy and clinical decision-making for Alzheimer disease and related disorders. Read the related article in . Disclosures can be found at .
info_outline
Optimal Timing of Anticoagulation After Ischemic Stroke and Atrial Fibrillation
Neurology® Podcast
Dr. Dan Ackerman talks with Dr. Urs Fischer about the optimal timing of anticoagulation after ischemic stroke in patients with atrial fibrillation. Read the related article in . Disclosures can be found at .
info_outlineThe May 2024 replay features four episodes on neuro-oncology for brain cancer awareness month. The episode begins with Dr. Philipp Karschnia discussing the assessment of whether MTHFR polymorphisms affect the risk for leukoencephalopathy. The episode continues with Dr. Ingo Mellinghoff discussing new treatment opinions for isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. The third interview leads into a conversation with Dr. Linda Liau on the study of vaccine-based therapy for GBM. The episode concludes with Dr. Teddy Totimeh talking about brain tumor programs in Asia and Africa.
Podcast Links:
MTHFR Polymorphisms and Leukoencephalopathy Risk in CNS Lymphoma Patients
New Treatment for IDH mt Gliomas
Study of Vaccine-Based Therapy for GBM
Brain Tumor Programs in Asia and Africa
Article Links:
https://doi.org/10.1212/WNL.0000000000207670
https://www.nejm.org/doi/full/10.1056/NEJMoa2304194
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
https://doi.org/10.1016/j.wneu.2023.04.067
Disclosures can be found at Neurology.org.